Predict your next investment

Asset/Investment Management
wasatchfunds.com

See what CB Insights has to offer

Investments

35

Portfolio Exits

19

About Wasatch Advisors

Wasatch Advisors is an employee owned investment manager.

Wasatch Advisors Headquarter Location

150 Social Hall Avenue 4th Floor

Salt Lake City, Utah, 84111,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Wasatch Advisors News

Bulk Deals | Kedaara-owned Karakoram offloads 7% stake in Vijaya Diagnostic Centre

Mar 7, 2022

Investor Karakoram has offloaded total 72,94,115 equity shares in the company at an average price of Rs 425.75 per share, as per the bulk deals data. Trade × India-focussed private equity firm Kedaara-owned Karakoram has sold 7.1 percent equity stake in diagnostic chain Vijaya Diagnostic Centre via open market transactions on March 7. Investor Karakoram has offloaded total 72,94,115 equity shares in the company at an average price of Rs 425.75 per share, as per the bulk deals data. At the end of December 2021, Karakoram held 9.64 percent shareholding or 98.29 lakh shares in Vijaya Diagnostic Centre . However, the 95 percent of shares sold by Karakoram has been bought by three investors AL Mehwar Commercial Investments LLC, Destinations International EQ Fund, and Wasatch Advisors Inc. AL Mehwar Commercial Investments LLC acquired 20,35,857 equity shares, Destinations International EQ Fund A Series of Brinker Capital Destinations Trust bought 8,94,610 equity shares, and Wasatch Advisors Inc through its funds - Wasatch Emerging India Fund and Wasatch International Opportunities Fund - purchased 40.1 lakh equity shares in Vijaya Diagnostic. These shares were bought at an average price of Rs 425.75 per share.

Wasatch Advisors Investments

35 Investments

Wasatch Advisors has made 35 investments. Their latest investment was in Medallia as part of their Series F on February 2, 2019.

CBI Logo

Wasatch Advisors Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

2/27/2019

Series F

Medallia

$70M

Yes

3

5/12/2015

Series F

DocuSign

$233M

Yes

36

5/1/2015

Series A

iVeena Delivery Systems

$1.3M

Yes

2

9/4/2014

Series E

Subscribe to see more

$99M

Subscribe to see more

10

9/23/2010

Series C - II

Subscribe to see more

$99M

Subscribe to see more

0

Date

2/27/2019

5/12/2015

5/1/2015

9/4/2014

9/23/2010

Round

Series F

Series F

Series A

Series E

Series C - II

Company

Medallia

DocuSign

iVeena Delivery Systems

Subscribe to see more

Subscribe to see more

Amount

$70M

$233M

$1.3M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

36

2

10

0

Wasatch Advisors Portfolio Exits

19 Portfolio Exits

Wasatch Advisors has 19 portfolio exits. Their latest portfolio exit was Endologix on October 01, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/1/2020

Take Private

3

7/19/2019

IPO

$99M

2

4/27/2018

IPO

$99M

7

7/22/2013

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

4/17/2013

Acq - P2P

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/1/2020

7/19/2019

4/27/2018

7/22/2013

4/17/2013

Exit

Take Private

IPO

IPO

Acquired

Acq - P2P

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

3

2

7

10

10

Wasatch Advisors Team

3 Team Members

Wasatch Advisors has 3 team members, including current Managing Director, Karey Barker.

Name

Work History

Title

Status

Karey Barker

Managing Director

Current

Eugene Podsiadlo

Managing Director

Current

Greg Bohlen

Morgan Creek Capital Management, Transoma Medical, Cross Creek, and UBS Investment Bank

Managing Director

Former

Name

Karey Barker

Eugene Podsiadlo

Greg Bohlen

Work History

Morgan Creek Capital Management, Transoma Medical, Cross Creek, and UBS Investment Bank

Title

Managing Director

Managing Director

Managing Director

Status

Current

Current

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.